New Alzheimer’s disease study seen as a potential “game changer”
The Anti-Amyloid Treatment in Asymptomatic Alzheimer’s Disease (A4) Study, a pioneering Alzheimer’s prevention trial, will test whether a drug called solanezumab can slow down or even prevent Alzheimer’s. Study participants aren’t yet exhibiting signs of memory loss, but they have brain scans suggesting they will develop Alzheimer’s.
http://www.optimumseniorcare.com/services/alzheimerscare.php